Tools to define the melanoma-associated immunopeptidome
Author:
Affiliation:
1. Medizinische Klinik III; Klinikum rechts der Isar; Technische Universität München; Munich Germany
2. German Cancer Consortium of Translational Cancer Research (DKTK) and German Cancer Research Centre (DKFZ); Heidelberg Germany
Funder
Wilhelm Sander-Stiftung
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/imm.12803/fullpdf
Reference130 articles.
1. Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon α-2b versus observation in resected stage III melanoma;Eggermont;J Clin Oncol,2012
2. Cancer regression in patients after transfer of genetically engineered lymphocytes;Morgan;Science,2006
3. Vaccine therapy for melanoma: current status and future directions;Terando;Vaccine,2007
4. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma;Schwartzentruber;N Engl J Med,2011
5. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen;Johnson;Blood,2009
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A recombinant pseudorabies virus surface - displaying the classical swine fever E2 protein induces specific antibodies rapidly;Veterinary Microbiology;2024-11
2. Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade;Science Immunology;2022-09-02
3. Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity;Expert Opinion on Drug Safety;2021-12-27
4. Changing the landscape of tumor immunology: novel tools to examine T cell specificity;Current Opinion in Immunology;2021-04
5. Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF;Frontiers in Immunology;2020-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3